X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/tersera-presents-patient-reported-clinical-and-productivity-outcomes-associated-with-xermelo-telotristat-ethyl--long-term-registry-trial-of-patients-with-carcinoid-syndrome-diarrhea-301420201.html
https://www.prnewswire.com/news-releases/tersera-announces-publication-of-real-world-study-on-xermelo-telotristat-ethyl-in-patients-with-carcinoid-syndrome-diarrhea-301409241.html
https://endpts.com/lexicon-bids-farewell-to-top-seller-xermelo-in-reorganization-toward-rd-pipeline/
https://www.globenewswire.com/news-release/2020/05/13/2033081/0/en/Lexicon-Pharmaceuticals-Announces-Preclinical-Efficacy-Data-on-Telotristat-Ethyl-s-Antiproliferative-Effects-Against-Various-Cancer-Cell-Lines.html
https://globenewswire.com/news-release/2018/07/30/1543761/0/en/Lexicon-Pharmaceuticals-Reports-Second-Quarter-2018-Financial-Results-and-Provides-a-Business-Update.html
http://www.lexpharma.com/media-center/news/668-lexicon-pharmaceuticals-to-highlight-pipeline-progress-at-r-d-day-on-april-10-2018
http://www.lexpharma.com/media-center/news/673-fda-to-review-zynquista-sotagliflozin-as-potential-treatment-for-type-1-diabetes
http://www.lexpharma.com/media-center/news/672-lexicon-pharmaceuticals-announces-publication-of-new-xermelo-telotristat-ethyl-data-in-clinical-therapeutics
http://www.lexpharma.com/media-center/news/652-uropean-commission-approves-xermelo-telotristat-ethyl-for-the-treatment-of-carcinoid-syndrome-diarrhea-in-combination-with-somatostatin-analog-therapy
Market Place
Share 
